CASC
First Eagle Investment Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-24,999
| Closed | -$108K | – | 339 |
|
|
2016
Q4 | $108K | Sell |
24,999
-375,001
| -94% | -$1.62M | ﹤0.01% | 263 |
|
|
2016
Q3 | $656K | Hold |
400,000
| – | – | ﹤0.01% | 252 |
|
|
2016
Q2 | $377K | Buy |
400,000
+100,000
| +33% | +$94.3K | ﹤0.01% | 276 |
|
|
2016
Q1 | $381K | Hold |
300,000
| – | – | ﹤0.01% | 263 |
|
|
2015
Q4 | $666K | Buy |
+300,000
| New | +$666K | ﹤0.01% | 237 |
|
|
2015
Q2 | – | Sell |
-1,300,000
| Closed | -$2.12M | – | 330 |
|
|
2015
Q1 | $2.12M | Buy |
+1,300,000
| New | +$2.12M | 0.01% | 205 |
|
|
2014
Q3 | – | Sell |
-2,384,039
| Closed | -$7.72M | – | 353 |
|
|
2014
Q2 | $7.72M | Sell |
2,384,039
-340,948
| -13% | -$1.1M | 0.02% | 179 |
|
|
2014
Q1 | $8.15M | Buy |
2,724,987
+100,000
| +4% | +$299K | 0.02% | 147 |
|
|
2013
Q4 | $4.62M | Buy |
2,624,987
+349,700
| +15% | +$615K | 0.01% | 170 |
|
|
2013
Q3 | $4.69M | Buy |
2,275,287
+979,788
| +76% | +$2.02M | 0.01% | 182 |
|
|
2013
Q2 | $2.02M | Buy |
+1,295,499
| New | +$2.02M | 0.01% | 225 |
|